Yuesong Pan Selected Research

Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)

1/2023	Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-risk TIA with intracranial or extracranial atherosclerosis (INSPIRES).
12/2022	A score to predict the stroke recurrence of patients with embolic stroke of undetermined source.
1/2021	Residual Risk and Its Risk Factors for Ischemic Stroke with Adherence to Guideline-Based Secondary Stroke Prevention.
1/2018	Statin Use during Hospitalization and Short-Term Mortality in Acute Ischaemic Stroke with Chronic Kidney Disease.
11/2014	Web-based tool for dynamic functional outcome after acute ischemic stroke and comparison with existing models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuesong Pan Research Topics

Disease

137	Stroke (Strokes) 05/2024 - 01/2013
126	Ischemic Stroke 06/2024 - 01/2014
50	Transient Ischemic Attack 01/2024 - 06/2014
22	Hemorrhage 05/2024 - 07/2015
15	Insulin Resistance 02/2024 - 01/2017
14	Diabetes Mellitus 01/2023 - 08/2013
13	Pathologic Constriction (Stenosis) 12/2023 - 01/2013
11	Infarction (Infarctions) 06/2024 - 01/2018
9	Atherosclerosis 12/2023 - 08/2018
9	Atrial Fibrillation 03/2023 - 05/2013
9	Prediabetic State (Prediabetes) 01/2023 - 09/2014
8	Cognitive Dysfunction 01/2024 - 01/2019
8	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 01/2017
6	Inflammation (Inflammations) 04/2024 - 01/2019
6	Hyperglycemia 01/2023 - 11/2017
5	Hypertension (High Blood Pressure) 03/2024 - 01/2019
5	Atherosclerotic Plaque (Atheroma) 12/2023 - 10/2022
5	Intracranial Hemorrhages (Intracranial Hemorrhage) 04/2023 - 03/2015
5	Cerebral Small Vessel Diseases 11/2022 - 01/2014
5	Chronic Renal Insufficiency 01/2022 - 01/2018
5	Cerebral Hemorrhage 01/2019 - 10/2015
4	Brain Ischemia (Cerebral Ischemia) 01/2024 - 08/2013
4	Coronary Artery Disease (Coronary Atherosclerosis) 10/2023 - 01/2022
4	Type 2 Diabetes Mellitus (MODY) 11/2020 - 01/2018
3	Thrombosis (Thrombus) 07/2023 - 04/2019
3	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 07/2023 - 06/2016
3	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 12/2019
2	Hemorrhagic Stroke 05/2024 - 01/2018
2	Reperfusion Injury 01/2024 - 02/2019
2	Cerebral Infarction 04/2023 - 01/2021
2	Coronary Disease (Coronary Heart Disease) 01/2023 - 01/2022
2	Pain (Aches) 01/2021 - 01/2018
2	Myocardial Infarction 05/2020 - 04/2019
2	Hematoma 07/2018 - 11/2013
2	Deglutition Disorders (Dysphagia) 01/2017 - 05/2013
2	Heart Failure 02/2016 - 05/2013
2	Leukoaraiosis 11/2014 - 01/2014
1	Sarcopenia 04/2024
1	Malnutrition (Nutritional Deficiencies) 04/2024
1	Carotid Artery Diseases 12/2023

Drug/Important Bio-Agent (IBA)

38	Clopidogrel (Plavix)FDA Link 05/2024 - 06/2014
32	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2024 - 06/2014
31	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 09/2014
17	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2024 - 01/2014
15	Cytochrome P-450 CYP2C19IBA 05/2024 - 07/2016
14	TicagrelorIBA 05/2024 - 01/2017
13	C-Reactive ProteinIBA 09/2023 - 01/2013
10	AlbuminsIBA 04/2024 - 11/2017
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2019
8	Hemoglobins (Hemoglobin)IBA 01/2024 - 01/2016
8	Indicators and Reagents (Reagents)IBA 01/2024 - 01/2014
8	Triglycerides (Triacylglycerol)IBA 01/2023 - 11/2015
7	Cystatin CIBA 04/2024 - 01/2021
7	Insulin (Novolin)FDA Link 12/2023 - 01/2018
7	danaparoid (Orgaran)FDA Link 01/2023 - 01/2016
7	Blood Glucose (Blood Sugar)IBA 01/2020 - 05/2013
6	CholesterolIBA 03/2024 - 12/2020
6	oxidized low density lipoproteinIBA 07/2023 - 01/2021
6	LDL CholesterolIBA 07/2023 - 01/2021
5	CreatinineIBA 04/2024 - 01/2022
5	Tenecteplase FDA Link 01/2024 - 01/2022
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 11/2014
4	HDL CholesterolIBA 03/2024 - 12/2021
4	LipidsIBA 01/2023 - 01/2019
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 05/2024 - 01/2021
3	Fibrinogen (Factor I)FDA Link 04/2024 - 07/2023
3	Nonesterified Fatty Acids (NEFA)IBA 12/2023 - 01/2020
3	Antihypertensive Agents (Antihypertensives)IBA 10/2023 - 01/2021
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 05/2023 - 01/2019
3	Uric Acid (Urate)IBA 10/2022 - 02/2017
3	Lipoprotein(a)IBA 07/2022 - 12/2019
3	Interleukin-6 (Interleukin 6)IBA 06/2022 - 01/2021
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2020 - 09/2014
2	MelatoninIBA 01/2024 - 02/2019
2	Therapeutic UsesIBA 01/2024 - 02/2019
2	Phenobarbital (Luminal)FDA Link 12/2023 - 01/2020
2	Apolipoproteins B (ApoB)IBA 07/2023 - 12/2022
2	ApolipoproteinsIBA 07/2023 - 12/2022
2	Tirofiban (Aggrastat)FDA Link 05/2023 - 01/2021
2	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2023 - 06/2022
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2023 - 12/2020
2	indobufenIBA 01/2023 - 10/2022
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 06/2022 - 02/2020
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 06/2022 - 02/2020
2	HomocysteineIBA 12/2021 - 07/2018
2	AnticoagulantsIBA 01/2021 - 01/2019
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2024
1	pumiceIBA 01/2024
1	AutoantigensIBA 09/2023
1	muskIBA 09/2023
1	AutoantibodiesIBA 09/2023

Therapy/Procedure

50	Therapeutics 06/2024 - 01/2013
15	Secondary Prevention 01/2023 - 06/2017
13	Thrombectomy 05/2024 - 06/2016
5	Stents 05/2020 - 08/2018
3	Length of Stay 01/2017 - 03/2014
2	Punctures 01/2021 - 01/2021
2	Glycemic Control 01/2019 - 01/2018
1	Decompressive Craniectomy 02/2024
1	Time-to-Treatment 01/2024